Gland Pharma Ltd shares continued their upward momentum, trading at ₹2,510.4 with a 1.92% gain as of 12:49 IST on the NSE. According to reports from IDBI Capital Market Pages, this marks the third consecutive session of gains for the pharmaceutical company. The stock has demonstrated strong performance over longer timeframes, gaining 32.94% in the last one year, significantly outperforming the 4.13% jump in the NIFTY and 16.41% increase in the Nifty Pharma index.
The broader market showed mixed performance during the session. As reported by IDBI Capital Market Pages, the benchmark NIFTY was up around 0.16%, trading at 24,468.6, while the Sensex stood at 78,452.78, gaining 0.21%. The Nifty Pharma index, of which Gland Pharma is a constituent, has gained approximately 6.86% in the last one month and was currently quoted at 25,866.25, down 0.24% on the day.
Latest data from IDBI Capital Market Pages shows that Gland Pharma has gained 11.68% in the last one month, demonstrating sustained momentum beyond its three-session winning streak. This recent performance aligns with the company's strong annual returns, with the stock significantly outperforming both the broader market and sector indices over the longer term.
Trading volume for Gland Pharma shares stood at 6.18 lakh shares during the session, as reported by IDBI Capital Market Pages. This represents a lower volume compared to the daily average of 8.44 lakh shares recorded over the last one month. The PE ratio of the stock stands at 30.83 based on trailing twelve months earnings ending March 2026.
